Vetoquinol SA

V?toquinol is a global player in the animal health sector, serving both the livestock (cattle and pigs) and pet (dogs and cats) markets. Co. designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region, as an independent entity. Co. is also active in the therapeutic fields of anti-infectives, pain-inflammation and cardiology-nephrology treatment. As of Dec 31 2013, Co.'s product portfolio included brands such as Aurizon®, Epiphen®, Ipakitine®, Marbocyl®, Propalin®, Tolf?dine®, Tolfine®, Clavaseptin®, and Vetprofen®. Co.'s brands are V?toquinol, Tomlyn, and Evsco in the U.S.A. and Equistro for the horse range.
  • TickerVETO
  • ISINFR0004186856
  • ExchangeEuronext Paris
  • SectorPharmaceuticals & Biotechnology
  • CountryFrance

VETOQUINOL loses on its star level and is downgraded to Slightly Positive

The independent financial analyst theScreener just slightly lowered the general evaluation of VETOQUINOL (FR), active in the Pharmaceuticals industry. The title has lost a star(s) at the fundamental level and now shows 2 out of 4 stars. Its exposure to market risk remains nonetheless the same and can be still described as defensive. theScreener slightly downgrades the general evaluation to Slightly Positive for the title on account of the lost star(s). As of the analysis date May 15, 2020, the closing price was EUR 54.00 and its potential was estimated at EUR 65.94.

Ahmed Ben Salem ...
  • Alain William
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Benoit Valleaux
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emmanuel Matot
  • Geoffroy Michalet
  • Jean Sassus
  • Jerôme Bodin
  • Louis Boujard, CFA
  • Olfa Taamallah
  • Philippe Ourpatian
  • Pierre Tegner
  • Roland Pfaender,MBA,CFA,CCRA
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/04/2020

...

Christophe-Raphaël Ganet

ODDO : Update

>Resilience confirmed: Q1 sales: +6% - To date, the sector has reported around 6% growth in Q1 revenues (Q2 will be more impacted: -10%e in our models). At the same time, we have lowered, on average, our projections by around 3% on 2020e revenues and by 9% on 2020e OIR.Finally, in the crisis, half of the issuers have, at this stage, cancelled the payment of their dividend.Performances: +14% (over the last 2 months) - At the same time, the sector'...

Alain William ...
  • Aurelien Sivignon
  • Baptiste Lebacq
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 04/05/2020 Date Performance depuis l’entrée Date Performance depuis l’entrée

...

Christophe-Raphaël Ganet

ODDO : Update

>Resilience confirmed: Q1 sales: +6% - To date, the sector has reported around 6% growth in Q1 revenues (Q2 will be more impacted: -10%e in our models). At the same time, we have lowered, on average, our projections by around 3% on 2020e revenues and by 9% on 2020e OIR.Finally, in the crisis, half of the issuers have, at this stage, cancelled the payment of their dividend.Performances: +14% (over the last 2 months) - At the same time, the sector'...

Christophe-Raphaël Ganet

ODDO : Update Santé

>Résilience plutôt confortée: CA T1: +6% - A ce jour, le secteur a publié une croissance d’environ 6% des CA T1 (T2 sera plus impacté : -10%e dans nos modèles). Dans le même temps, nous avons abaissé, en moyenne, nos projections d’environ 3% sur le CA 2020e, et de 9%, au niveau du ROC 2020e.Enfin, dans la crise, la moitié des émetteurs ont, à ce stade, annulé le versement de leur dividende.Performance boursière: +14% (sur les 2 derniers mois) - P...

Christophe-Raphaël Ganet

Vetoquinol : Strong Q1 2020 sales (storage effect), cannot be extrapolated

>Q1 (+14%) above our expectations (precautionary purchases) - Vétoquinol published Q1 2020 sales of € 103.4m, (+13.7% and +13.4% at constant currency), including € 53.4m in essential products (+17.9% at constant currency / 51.6% of sales vs 48.4% for secondary products). Sales products intended for pets at € 60.1m represent 58.1% of the revenue (+15.1% at cc) compared to € 43.3m for production animals (41.9% of sales): +10.9% at cc.The group gave no guidance...

Christophe-Raphaël Ganet

Vetoquinol : Fort CA T1 2020 (effet de stockage), non extrapolable

>T1 (+14%) supérieur à notre attente (achats de précaution) - Vétoquinol publie un CA T1 2020 à 103.4 M€, (+13.7% et +13.4% à tcc.) dont 53.4 M€ sur les produits Essentiels (+17.9% à tcc./ 51.6% des ventes vs 48.4% pour les produits Secondaires). Le CA des produits destinés aux Animaux de compagnie à 60.1 M€ représentent 58.1% du CA (+15,1% à tcc.) contre 43.3 M€ pour Animaux de rente (41.9% du CA) : +10.9% à tcc.Le groupe ne donne pas de guidance et précise...

Christophe-Raphaël Ganet

ODDO : Q1 2020 previews

>Recent contact with companies in the sector - Here we outline our main takeaways from our recent contact with a number of companies (Boiron, Bastide, bioMérieux and Ipsen).Generally, the tone was not one of doom and gloom, and the resilience in sales is being confirmed (the defensive qualities of the healthcare sector are coming through fully).Q1 previews (+5% estimated) - In this update, we are giving our previews for the stocks in our coverage...

Ahmed Ben Salem ...
  • Alain William
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Benoit Valleaux
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emmanuel Matot
  • Geoffroy Michalet
  • Jean Sassus
  • Jerôme Bodin
  • Louis Boujard, CFA
  • Olfa Taamallah
  • Philippe Ourpatian
  • Pierre Tegner
  • Roland Pfaender,MBA,CFA,CCRA
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/04/2020

...

Alain William ...
  • Aurelien Sivignon
  • Baptiste Lebacq
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 04/05/2020 Date Performance depuis l’entrée Date Performance depuis l’entrée

...

Ahmed Ben Salem ...
  • Alain William
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Baptiste Lebacq
  • Benoit Valleaux
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emmanuel Matot
  • Geoffroy Michalet
  • Jean Sassus
  • Jerôme Bodin
  • Louis Boujard, CFA
  • Olfa Taamallah
  • Philippe Ourpatian
  • Pierre Tegner
  • Roland Pfaender,MBA,CFA,CCRA
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 04/05/2020

...

Benoit Valleaux ...
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Fatma Agnès Hamdani
  • Florent Laroche-Joubert
  • Jerôme Bodin
  • Nicolas Thorez
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 04/17/2020

The impacts of the COVID-19 pandemic are massive on the hotel/leisure sector (2020e EPS forecast down 41%). They undermine the weakest players. Our preference henceforth goes to the most resilient business models and the most solid balance sheets; Advantage Accor and Whitbread. - ...

VETOQUINOL loses on its star level and is downgraded to Slightly Positive

The independent financial analyst theScreener just slightly lowered the general evaluation of VETOQUINOL (FR), active in the Pharmaceuticals industry. The title has lost a star(s) at the fundamental level and now shows 2 out of 4 stars. Its exposure to market risk remains nonetheless the same and can be still described as defensive. theScreener slightly downgrades the general evaluation to Slightly Positive for the title on account of the lost star(s). As of the analysis date May 15, 2020, the closing price was EUR 54.00 and its potential was estimated at EUR 65.94.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Florian Béchaz

Vétoquinol S.A. - Assemblée Générale des actionnaires du 21 mai 2019

Proxinvest attire l'attention des actionnaires sur les points suivants : Tout d'abord, notons que le Conseil d'administration de la société est largement composé par la famille Frechin, actionnaire de contrôle, qui est représentée par 4 sièges sur 8 (50%). Par ailleurs, Proxinvest regrette que la société maintienne la possibilité de l'usage de ses délégations financières en période d'offre publique, ce qui n'est pas favorable aux intérêts des actionnaires puisque cela peut être considéré comme la mise en place d'un arsenal anti-OPA. Enfin, la communication de la société concernant les rémuné...

Jehanne Leroy

Proxy Report - 29/05/2018

Proxinvest attire l'attention des actionnaires sur les points suivants : Tout d'abord, notons que le Conseil d'administration de la société est largement dominé par la famille Frechin, actionnaire de contrôle, qui est représentée par 5 sièges sur 9 (55,6%). Par ailleurs, Proxinvest regrette que la société maintienne la possibilité de l'usage de ses délégations financières en période d'offre publique, ce qui n'est pas favorable aux intérêts des actionnaires puisque cela peut être considéré comme la mise en place d'un arsenal anti-OPA. Enfin, la communication de la société concernant les rémun...

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

SRI Company Analysis

Geol analyses are ESG (Environment, Social, Governance) analyses covering European large caps and small and mid caps, listed or non-listed. Those analyses, based on the ESG risks identified, show the qualitative and quantitative performance of issuers, in a ten-page synthesis.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch